0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Screening Market Insights and Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-2I7206
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Drug Screening Market Insights and Forecast to 2028

Global Drug Screening Market Insights and Forecast to 2028

Code: QYRE-Auto-2I7206
Report
February 2022
95 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Drug Screening Market Statistics 2028

Due to the COVID-19 pandemic, the global Drug Screening market size is estimated to be worth US$ 4567.1 million in 2022 and is forecast to a readjusted size of US$ 6333.1 million by 2028 with a CAGR of 5.6% during the review period.

Fully considering the economic change by this health crisis, Immunoassay Analyzers accounting for % of the Drug Screening global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

As for the Europe Drug Screening landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. The global key manufacturers of Drug Screening include Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare and Thermo Fisher Scientific. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Drug Screening Market

Drug Screening Market Segment Analysis

Drug Screening market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Drug Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Immunoassay Analyzers
  • Chromatography
  • Breath Analyzers
  • Rapid Testing Devices
  • Assay Kits and Reagents

Segment by Application

  • Hospitals
  • Research Institute
  • Biotechnology & Pharmaceutical Companies
  • Others

BY COMPANY

  • Abbott
  • Express Diagnostics
  • Laboratory Corporation of America
  • MPD
  • Quest Diagnostics
  • Roche Diagnostics
  • Shimadzu
  • Siemens Healthcare
  • Thermo Fisher Scientific

BY REGION

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Scope of the Drug Screening Market Report

Report Metric

Details

Report Name

Drug Screening Market 

The market size in 2022

USD 4567.1 Million

The revenue forecast in 2028

USD 6333.1 Million

Growth Rate

Compound Annual Growth Rate (CAGR) of 5.6% from 2022 to 2028

Market size available for years

2022-2028

Forecast units

Value (USD)

Segments covered

By Type, Application, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. How Big is the Drug Screening Market?

Ans. Drug Screening market size is estimated to be worth US$ 4567.1 million in 2022 and is forecast to a readjusted size of US$ 6333.1 million by 2028 with a CAGR of 5.6% during the review period.

2. What is the Drug Screening Market Growth?

Ans. Drug Screening market is expected to grow at a compound annual growth rate of 5.6% from 2022 to 2028.

3. Who are the major key players of the Drug Screening Market?

Ans. Some of the major companies are Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific.

1 Study Coverage
1.1 Drug Screening Product Introduction
1.2 Market by Type
1.2.1 Global Drug Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunoassay Analyzers
1.2.3 Chromatography
1.2.4 Breath Analyzers
1.2.5 Rapid Testing Devices
1.2.6 Assay Kits and Reagents
1.3 Market by Application
1.3.1 Global Drug Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Research Institute
1.3.4 Biotechnology & Pharmaceutical Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug Screening Sales Estimates and Forecasts 2017-2028
2.2 Global Drug Screening Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug Screening Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug Screening Sales by Region
2.4.1 Global Drug Screening Sales by Region (2017-2022)
2.4.2 Global Sales Drug Screening by Region (2023-2028)
2.5 Global Drug Screening Revenue by Region
2.5.1 Global Drug Screening Revenue by Region (2017-2022)
2.5.2 Global Drug Screening Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug Screening Sales by Manufacturers
3.1.1 Global Top Drug Screening Manufacturers by Sales (2017-2022)
3.1.2 Global Drug Screening Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Screening in 2021
3.2 Global Drug Screening Revenue by Manufacturers
3.2.1 Global Drug Screening Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug Screening Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug Screening Revenue in 2021
3.3 Global Drug Screening Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug Screening Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug Screening Sales by Type
4.1.1 Global Drug Screening Historical Sales by Type (2017-2022)
4.1.2 Global Drug Screening Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug Screening Sales Market Share by Type (2017-2028)
4.2 Global Drug Screening Revenue by Type
4.2.1 Global Drug Screening Historical Revenue by Type (2017-2022)
4.2.2 Global Drug Screening Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug Screening Revenue Market Share by Type (2017-2028)
4.3 Global Drug Screening Price by Type
4.3.1 Global Drug Screening Price by Type (2017-2022)
4.3.2 Global Drug Screening Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug Screening Sales by Application
5.1.1 Global Drug Screening Historical Sales by Application (2017-2022)
5.1.2 Global Drug Screening Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug Screening Sales Market Share by Application (2017-2028)
5.2 Global Drug Screening Revenue by Application
5.2.1 Global Drug Screening Historical Revenue by Application (2017-2022)
5.2.2 Global Drug Screening Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug Screening Revenue Market Share by Application (2017-2028)
5.3 Global Drug Screening Price by Application
5.3.1 Global Drug Screening Price by Application (2017-2022)
5.3.2 Global Drug Screening Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug Screening Market Size by Type
6.1.1 North America Drug Screening Sales by Type (2017-2028)
6.1.2 North America Drug Screening Revenue by Type (2017-2028)
6.2 North America Drug Screening Market Size by Application
6.2.1 North America Drug Screening Sales by Application (2017-2028)
6.2.2 North America Drug Screening Revenue by Application (2017-2028)
6.3 North America Drug Screening Market Size by Country
6.3.1 North America Drug Screening Sales by Country (2017-2028)
6.3.2 North America Drug Screening Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Drug Screening Market Size by Type
7.1.1 Europe Drug Screening Sales by Type (2017-2028)
7.1.2 Europe Drug Screening Revenue by Type (2017-2028)
7.2 Europe Drug Screening Market Size by Application
7.2.1 Europe Drug Screening Sales by Application (2017-2028)
7.2.2 Europe Drug Screening Revenue by Application (2017-2028)
7.3 Europe Drug Screening Market Size by Country
7.3.1 Europe Drug Screening Sales by Country (2017-2028)
7.3.2 Europe Drug Screening Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug Screening Market Size by Type
8.1.1 Asia Pacific Drug Screening Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug Screening Revenue by Type (2017-2028)
8.2 Asia Pacific Drug Screening Market Size by Application
8.2.1 Asia Pacific Drug Screening Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug Screening Revenue by Application (2017-2028)
8.3 Asia Pacific Drug Screening Market Size by Region
8.3.1 Asia Pacific Drug Screening Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug Screening Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Drug Screening Market Size by Type
9.1.1 Latin America Drug Screening Sales by Type (2017-2028)
9.1.2 Latin America Drug Screening Revenue by Type (2017-2028)
9.2 Latin America Drug Screening Market Size by Application
9.2.1 Latin America Drug Screening Sales by Application (2017-2028)
9.2.2 Latin America Drug Screening Revenue by Application (2017-2028)
9.3 Latin America Drug Screening Market Size by Country
9.3.1 Latin America Drug Screening Sales by Country (2017-2028)
9.3.2 Latin America Drug Screening Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drug Screening Market Size by Type
10.1.1 Middle East and Africa Drug Screening Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug Screening Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug Screening Market Size by Application
10.2.1 Middle East and Africa Drug Screening Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug Screening Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug Screening Market Size by Country
10.3.1 Middle East and Africa Drug Screening Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug Screening Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Express Diagnostics
11.2.1 Express Diagnostics Corporation Information
11.2.2 Express Diagnostics Overview
11.2.3 Express Diagnostics Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Express Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Express Diagnostics Recent Developments
11.3 Laboratory Corporation of America
11.3.1 Laboratory Corporation of America Corporation Information
11.3.2 Laboratory Corporation of America Overview
11.3.3 Laboratory Corporation of America Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Laboratory Corporation of America Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Laboratory Corporation of America Recent Developments
11.4 MPD
11.4.1 MPD Corporation Information
11.4.2 MPD Overview
11.4.3 MPD Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MPD Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MPD Recent Developments
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Corporation Information
11.5.2 Quest Diagnostics Overview
11.5.3 Quest Diagnostics Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Quest Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Quest Diagnostics Recent Developments
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Corporation Information
11.6.2 Roche Diagnostics Overview
11.6.3 Roche Diagnostics Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Roche Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Roche Diagnostics Recent Developments
11.7 Shimadzu
11.7.1 Shimadzu Corporation Information
11.7.2 Shimadzu Overview
11.7.3 Shimadzu Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shimadzu Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shimadzu Recent Developments
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Corporation Information
11.8.2 Siemens Healthcare Overview
11.8.3 Siemens Healthcare Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Siemens Healthcare Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Siemens Healthcare Recent Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Corporation Information
11.9.2 Thermo Fisher Scientific Overview
11.9.3 Thermo Fisher Scientific Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Thermo Fisher Scientific Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Thermo Fisher Scientific Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug Screening Industry Chain Analysis
12.2 Drug Screening Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Screening Production Mode & Process
12.4 Drug Screening Sales and Marketing
12.4.1 Drug Screening Sales Channels
12.4.2 Drug Screening Distributors
12.5 Drug Screening Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug Screening Industry Trends
13.2 Drug Screening Market Drivers
13.3 Drug Screening Market Challenges
13.4 Drug Screening Market Restraints
14 Key Findings in The Global Drug Screening Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Drug Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Immunoassay Analyzers
    Table 3. Major Manufacturers of Chromatography
    Table 4. Major Manufacturers of Breath Analyzers
    Table 5. Major Manufacturers of Rapid Testing Devices
    Table 6. Major Manufacturers of Assay Kits and Reagents
    Table 7. Global Drug Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Drug Screening Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Drug Screening Sales by Region (2017-2022) & (K Units)
    Table 10. Global Drug Screening Sales Market Share by Region (2017-2022)
    Table 11. Global Drug Screening Sales by Region (2023-2028) & (K Units)
    Table 12. Global Drug Screening Sales Market Share by Region (2023-2028)
    Table 13. Global Drug Screening Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Drug Screening Revenue Market Share by Region (2017-2022)
    Table 15. Global Drug Screening Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Drug Screening Revenue Market Share by Region (2023-2028)
    Table 17. Global Drug Screening Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Drug Screening Sales Share by Manufacturers (2017-2022)
    Table 19. Global Drug Screening Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Drug Screening Revenue Share by Manufacturers (2017-2022)
    Table 21. Drug Screening Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Drug Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Drug Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Screening as of 2021)
    Table 24. Drug Screening Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Drug Screening Product Offered
    Table 26. Date of Manufacturers Enter into Drug Screening Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Drug Screening Sales by Type (2017-2022) & (K Units)
    Table 29. Global Drug Screening Sales by Type (2023-2028) & (K Units)
    Table 30. Global Drug Screening Sales Share by Type (2017-2022)
    Table 31. Global Drug Screening Sales Share by Type (2023-2028)
    Table 32. Global Drug Screening Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Drug Screening Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Drug Screening Revenue Share by Type (2017-2022)
    Table 35. Global Drug Screening Revenue Share by Type (2023-2028)
    Table 36. Drug Screening Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Drug Screening Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Drug Screening Sales by Application (2017-2022) & (K Units)
    Table 39. Global Drug Screening Sales by Application (2023-2028) & (K Units)
    Table 40. Global Drug Screening Sales Share by Application (2017-2022)
    Table 41. Global Drug Screening Sales Share by Application (2023-2028)
    Table 42. Global Drug Screening Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Drug Screening Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Drug Screening Revenue Share by Application (2017-2022)
    Table 45. Global Drug Screening Revenue Share by Application (2023-2028)
    Table 46. Drug Screening Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Drug Screening Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Drug Screening Sales by Type (2017-2022) & (K Units)
    Table 49. North America Drug Screening Sales by Type (2023-2028) & (K Units)
    Table 50. North America Drug Screening Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Drug Screening Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Drug Screening Sales by Application (2017-2022) & (K Units)
    Table 53. North America Drug Screening Sales by Application (2023-2028) & (K Units)
    Table 54. North America Drug Screening Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Drug Screening Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Drug Screening Sales by Country (2017-2022) & (K Units)
    Table 57. North America Drug Screening Sales by Country (2023-2028) & (K Units)
    Table 58. North America Drug Screening Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Drug Screening Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Drug Screening Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Drug Screening Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Drug Screening Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Drug Screening Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Drug Screening Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Drug Screening Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Drug Screening Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Drug Screening Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Drug Screening Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Drug Screening Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Drug Screening Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Drug Screening Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Drug Screening Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Drug Screening Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Drug Screening Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Drug Screening Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Drug Screening Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Drug Screening Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Drug Screening Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Drug Screening Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Drug Screening Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Drug Screening Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Drug Screening Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Drug Screening Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Drug Screening Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Drug Screening Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Drug Screening Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Drug Screening Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Drug Screening Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Drug Screening Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Drug Screening Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Drug Screening Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Drug Screening Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Drug Screening Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Drug Screening Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Drug Screening Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Drug Screening Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Drug Screening Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Drug Screening Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Drug Screening Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Drug Screening Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Drug Screening Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Drug Screening Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Drug Screening Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Drug Screening Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Drug Screening Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Drug Screening Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Drug Screening Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Abbott Corporation Information
    Table 109. Abbott Description and Major Businesses
    Table 110. Abbott Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Abbott Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Abbott Recent Developments
    Table 113. Express Diagnostics Corporation Information
    Table 114. Express Diagnostics Description and Major Businesses
    Table 115. Express Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Express Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Express Diagnostics Recent Developments
    Table 118. Laboratory Corporation of America Corporation Information
    Table 119. Laboratory Corporation of America Description and Major Businesses
    Table 120. Laboratory Corporation of America Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Laboratory Corporation of America Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Laboratory Corporation of America Recent Developments
    Table 123. MPD Corporation Information
    Table 124. MPD Description and Major Businesses
    Table 125. MPD Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. MPD Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. MPD Recent Developments
    Table 128. Quest Diagnostics Corporation Information
    Table 129. Quest Diagnostics Description and Major Businesses
    Table 130. Quest Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Quest Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Quest Diagnostics Recent Developments
    Table 133. Roche Diagnostics Corporation Information
    Table 134. Roche Diagnostics Description and Major Businesses
    Table 135. Roche Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Roche Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Roche Diagnostics Recent Developments
    Table 138. Shimadzu Corporation Information
    Table 139. Shimadzu Description and Major Businesses
    Table 140. Shimadzu Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Shimadzu Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Shimadzu Recent Developments
    Table 143. Siemens Healthcare Corporation Information
    Table 144. Siemens Healthcare Description and Major Businesses
    Table 145. Siemens Healthcare Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Siemens Healthcare Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Siemens Healthcare Recent Developments
    Table 148. Thermo Fisher Scientific Corporation Information
    Table 149. Thermo Fisher Scientific Description and Major Businesses
    Table 150. Thermo Fisher Scientific Drug Screening Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Thermo Fisher Scientific Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Thermo Fisher Scientific Recent Developments
    Table 153. Key Raw Materials Lists
    Table 154. Raw Materials Key Suppliers Lists
    Table 155. Drug Screening Distributors List
    Table 156. Drug Screening Customers List
    Table 157. Drug Screening Market Trends
    Table 158. Drug Screening Market Drivers
    Table 159. Drug Screening Market Challenges
    Table 160. Drug Screening Market Restraints
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug Screening Product Picture
    Figure 3. Global Drug Screening Market Share by Type in 2021 & 2028
    Figure 3. Immunoassay Analyzers Product Picture
    Figure 4. Chromatography Product Picture
    Figure 5. Breath Analyzers Product Picture
    Figure 6. Rapid Testing Devices Product Picture
    Figure 7. Assay Kits and Reagents Product Picture
    Figure 8. Global Drug Screening Market Share by Application in 2021 & 2028
    Figure 9. Hospitals
    Figure 10. Research Institute
    Figure 11. Biotechnology & Pharmaceutical Companies
    Figure 12. Others
    Figure 13. Drug Screening Report Years Considered
    Figure 14. Global Drug Screening Sales 2017-2028 (K Units)
    Figure 15. Global Drug Screening Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Drug Screening Revenue 2017-2028 (US$ Million)
    Figure 17. Global Drug Screening Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Drug Screening Sales Market Share by Region (2017-2022)
    Figure 19. Global Drug Screening Sales Market Share by Region (2023-2028)
    Figure 20. North America Drug Screening Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Drug Screening Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Drug Screening Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Drug Screening Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Drug Screening Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Drug Screening Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Drug Screening Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Drug Screening Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Drug Screening Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Drug Screening Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Drug Screening Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Drug Screening in the World: Market Share by Drug Screening Revenue in 2021
    Figure 32. Global Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Drug Screening Sales Market Share by Type (2017-2028)
    Figure 34. Global Drug Screening Revenue Market Share by Type (2017-2028)
    Figure 35. Global Drug Screening Sales Market Share by Application (2017-2028)
    Figure 36. Global Drug Screening Revenue Market Share by Application (2017-2028)
    Figure 37. North America Drug Screening Sales Market Share by Type (2017-2028)
    Figure 38. North America Drug Screening Revenue Market Share by Type (2017-2028)
    Figure 39. North America Drug Screening Sales Market Share by Application (2017-2028)
    Figure 40. North America Drug Screening Revenue Market Share by Application (2017-2028)
    Figure 41. North America Drug Screening Sales Share by Country (2017-2028)
    Figure 42. North America Drug Screening Revenue Share by Country (2017-2028)
    Figure 43. U.S. Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Drug Screening Sales Market Share by Type (2017-2028)
    Figure 46. Europe Drug Screening Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Drug Screening Sales Market Share by Application (2017-2028)
    Figure 48. Europe Drug Screening Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Drug Screening Sales Share by Country (2017-2028)
    Figure 50. Europe Drug Screening Revenue Share by Country (2017-2028)
    Figure 51. Germany Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 52. France Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Drug Screening Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Drug Screening Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Drug Screening Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Drug Screening Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Drug Screening Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Drug Screening Revenue Share by Region (2017-2028)
    Figure 62. China Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 65. India Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Drug Screening Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Drug Screening Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Drug Screening Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Drug Screening Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Drug Screening Sales Share by Country (2017-2028)
    Figure 77. Latin America Drug Screening Revenue Share by Country (2017-2028)
    Figure 78. Mexico Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Drug Screening Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Drug Screening Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Drug Screening Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Drug Screening Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Drug Screening Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Drug Screening Revenue Share by Country (2017-2028)
    Figure 87. Turkey Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Drug Screening Revenue (2017-2028) & (US$ Million)
    Figure 90. Drug Screening Value Chain
    Figure 91. Drug Screening Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global and United States Biologics Drug Development Market Report Forecast 2022 2028
Global and United States Biologics Drug Development Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
Global and United States Biologics Drug Discovery Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-0D6239
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Nanopharmaceutical Drugs Market Report Forecast 2022 2028
Global and United States Nanopharmaceutical Drugs Market Report & Forecast 2022-2028

The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.Market Analysis and Insights Global and United States Nanopharmaceutical Drugs MarketThis report focuses on global and United States Nanopharmaceutical Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Nanopharmaceutical Drugs market size is estimated to be worth US 35330 million in 2022 and is forecast to a readjusted size of US 72540 million by 2028 with a CAGR of 12.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24J10248
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Polymerase Chain Reaction Technology Market Report Forecast 2022 2028
Global and United States Polymerase Chain Reaction Technology Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7I6111
Tue Jun 07 00:00:00 UTC 2022

Add to Cart